HHLA2 and hepatocellular carcinoma: Patients with higher HHLA2 expression exhibited poorer anti-tumor immunological responses, suggesting that despite more abundant immune infiltrations, immune cells might be deprived of their functions in HCC with elevated HHLA2 expression [34,35].